Note: product reference (b)(4) is not cleared for sales in the usa, but it is similar to a product reference cleared under #510k130576.Batch history review: batch unknown.Investigation results: the device was not returned for evaluation.However a picture of the event was forwarded.We can see the access port implanted in the patient's chest: the access port housing is visible through the skin.The patient skin/scare over the access port is pierced and dry.No swelling is visible.We can see that the access port housing is located under the implantation scar.Conclusion: the access port exteriorization observed is a known complication of access port implantation.The image received seems to show that two factors could have contributed to this incident: - the fact that the access port housing was implanted just under the skin incision, not at one centimeter of the skin incision as recommended.The ifu specifies: vi-1-1 k) "ensure that the skin incision is 1 cm from the injection site." - the fact that the access port was implanted too superficially: the ifu specifies: vi-1-1 "f) prepare the port pocket at the chosen site, the port should lie approximately 1/2 - 1 cm below the skin surface away from the injection site." this is a rare incident not directly imputable to the device, no corrective action is envisaged for the moment.
|
Patient undergoing systemic management with highly toxic chemotherapy with flot scheme, comes for 3rd cycle administration showing evidence of dehiscence of the pocket wound of the implantable catheter with exposure of the device.It is not possible to use this access under these conditions, patient would require hospitalization to change the catheter and complete infusion of 5 fluorouracil.
|